INDVR Brands Inc.

OTC: CAAOF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Calgary, ABReports USD

#868 of 1,394 Healthcare companies by revenue58th-percentile growth

EA Score

——

FH —DQ —GM —SS 17

v0.1 · 5/100 weight · pillars only

↑ Piotroski F, revenue growth (YoY) · ↓ market scale, return on equity

Methodology →

Revenue TTM

$1.0M

Rev growth YoY (TTM)

+221.2%

Net income (FY)

-$5.9M

Employees

Market cap

$3.0k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$943.7k$943.7k2020

Net income-$5.9M-$5.9M2020

Operating income-$4.8M-$4.8M2020

Total assets$7.4M$7.4M2020

Liabilities$6.0M$6.0M2020

Equity$1.5M$1.5M2020

Revenue trend

FY2016 – FY2020 · USD

FY16

FY17

FY18

$844.1k

FY19

$943.7k

FY20

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

INDVR Brands Inc. booked $943.7k in FY2020 revenue, growing 12% year over year — about the middle of the pack among Healthcare companies we track, at a -628.5% net margin.

Peers · Healthcare

Acutus Medical, Inc.——Synovics Pharmaceuticals, Inc.——New Leaf Ventures Inc——Comera Life Sciences Holdings, Inc.——

Key facts

CEOHugh Hemple

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersCalgary, AB

ExchangeOTC: CAAOF

Employees3

IPO date2019-02-27

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.